Pfizer (BOM:500680) Moat Score: 0/10 (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500680 Pfizer Ltd BOM:500680
73 GF Score
Price ₹4,650.60
GF Value ₹4,888.44
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Pfizer Moat Score?

Pfizer has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Pfizer has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Pfizer might have No Moat - No discernible moat.

Pfizer  (BOM:500680) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Pfizer Moat Score Related Terms

BOM:500680
73GF Score
Pfizer Ltd BOM:500680
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pfizer (BOM:500680) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of ₹4,650.60 is trading 4.9% below its estimated GF Value™ of ₹4,888.44. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for BOM:500680:

  • Moat Score: 0
  • GF Value™: ₹4,888.44 vs. price of ₹4,650.60 (4.9% below fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the BOM:500680 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Other Exchanges PFIZER:India
Address The Capital, 1802/1901, 18th Floor, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company has only one segment which is Pharmaceuticals and it operates in domestic market.
73GF Score

Get the complete analysis for BOM:500680

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,650.60
Price
₹4,888.44
GF Value